Solid-state NMR studies of pharmaceutical systems

Applied Spectroscopy Reviews

Volumn 43, Issue 3, 2008, Pages 202-302

  Geppi, Marco ^a   Mollica, Giulia ^a   Borsacchi, Silvia ^a   Veracini, Carlo Alberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Active pharmaceutical ingredients; Drug formulations; Drug carrier interactions; Excipients; Polymorphism; Relaxation times; Structure and dynamics

Indexed keywords

DRUG PRODUCTS; IMAGE RESOLUTION; MORPHOLOGY; POLYMORPHISM; RELAXATION TIME; STRUCTURAL PROPERTIES;

ACTIVE PHARMACEUTICAL INGREDIENTS; DRUG FORMULATIONS; DRUG-CARRIER INTERACTIONS; SOLID-STATE NUCLEAR MAGNETIC RESONANCE (SSNMR);

NUCLEAR MAGNETIC RESONANCE;

EID: 40949105639     PISSN: 05704928     EISSN: 1520569X     Source Type: Journal    
DOI: 10.1080/05704920801944338     Document Type: Article

References (265)

1. Yu, L., Reutzel, S. M. and Stephenson, G. A. (1998) Physical characterization of polymorphic drugs: An integrated characterization strategy. Pharmaceutical Science &Technology Today, 1, pp. 118-127.
2. Bugay, D. E. (2001) Characterization of the solid-state: Spectroscopic techniques. Advanced Drug Delivery Reviews, 48, pp. 43-65.
3. Offerdahl, T. J. (2006) Solid-state nuclear magnetic resonance spectroscopy for analyzing polymorphic drug forms and formulations. Pharmaceutical Technology, p. 24.
4. Brittain, H. G., Bogdanowich, S. J., Bugay, D. E., DeVincentis, J., Lewen, G. and Newman, A. W. (1991) Physical characterization of pharmaceutical solids. Pharmaceutical Research, 8, pp. 963-973.
5. Brittain, H. G. (1997) Spectral methods for the characterization of polymorphs and solvates. Journal of Pharmaceutical Sciences, 86, pp. 405-412.
6. Stephenson, G. A., Forbes, R. A. and Reutzel-Edens, S. M. (2001) Characterization of the solid state: Quantitative issues. Advanced Drug Delivery Reviews, 48, pp. 67-90.
7. Byrn, S. R., Pfeiffer, R. R., Stephenson, G., Grant, D. J. W. and Gleason, W. B. (1994) Solid-state pharmaceutical chemistry. Chemistry of Materials, 6, pp. 1148-1158.
8. Shah, B., Kakumanu, V. K. and Bansal, A. K. (2006) Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. Journal of Pharmaceutical Sciences, 95, pp. 1641-1665.
9. Duer, M. J. (2002) Solid-State NMR Spectroscopy-Principles and Applications, Blackwell Science, Oxford
10. McBrierty, V. J. and Packer, K. J. (1993) Nuclear Magnetic Resonance in Solid Polymers, Cambridge University Press, Cambridge
11. Schmidt-Rohr, K. and Spiess, H. W. (1994) Multidimensional Solid-State NMR and Polymers, Academic Press, London
12. Saitâ, H., Ando, I. and Naito, A. (2006) Solid State NMR Spectroscopy for Biopolymers: Principles and Applications, Springer, Dordrecht, The Netherlands
13. Harris, R. K. and Wasylishen, R. E. Encyclopedia of Magnetic Resonance [online], John Wiley &Sons, Ltd
14. Webb, G. A. (2006) Modern Magnetic Resonance, Springer, Dordrecht, The Netherlands
15. Bugay, D. E. (1993) Solid-state nuclear magnetic resonance spectroscopy: Theory and pharmaceutical applications. Pharmaceutical Research, 10, pp. 317-327.
16. Tishmack, P. A., Bugay, D. E. and Byrn, S. R. (2003) Solid-state nuclear magnetic resonance spectroscopy-Pharmaceutical applications. Journal of Pharmaceutical Sciences, 92, pp. 441-474.
17. Berendt, R. T., Sperger, D. M., Isbester, P. K. and Munson, E. J. (2006) Solid-state NMR spectroscopy in pharmaceutical research and analysis. Trends in Analytical Chemistry, 25, pp. 977-984.
18. Harris, R. K. (2006) NMR studies of organic polymorphs &solvates. Analyst, 131, pp. 351-373.
19. Harris, R. K. (2007) Applications of solid-state NMR to pharmaceutical polymorphism and related matters. Journal of Pharmacy and Pharmacology, 59, pp. 225-239.
20. Munson, E. J. and Lubach, J. W. (2007) Solid-state NMR in the characterization of pharmaceutical formulations. Encyclopedia of Pharmaceutical Technology, 5, Informa Healthcare USA, New York
21. Holzgrabe, U., Diehl, B. W. K. and Wawer, I. (1998) NMR spectroscopy in pharmacy. Journal of Pharmaceutical and Biomedical Analysis, 17, pp. 557-616.
22. Byrn, S. R., Xu, W. and Newman, A. W. (2001) Chemical reactivity in solid-state pharmaceuticals: Formulation implications. Advanced Drug Delivery Reviews, 48, pp. 115-136.
23. Hilfiker, R. (2006) Polymorphism in the Pharmaceutical Industry, Wiley-VCH, Weinheim
24. Watts, A. (2005) Solid-state NMR in drug design and discovery for membrane-embedded targets. Nature Reviews Drug Discovery, 4, pp. 555-568.
25. Basting, D., Lehner, I., Lorch, M. and Glaubitz, C. (2006) Investigating transport proteins by solid state NMR. Naunyn-Schmiedeberg's Archives of Pharmacology, 372, pp. 451-464.
26. Auger, M. (2002) Biological and pharmaceutical applications of solid-state NMR spectroscopy. Canadian Journal of Analytical Sciences and Spectroscopy, 47, pp. 184-189.
27. Abragam, A. (1961) Principles of Nuclear Magnetism, Oxford University Press, London
28. Levitt, M. H. (2001) Spin Dynamics, John Wiley &Sons, Chichester
29. Keeler, J. (2005) Understanding NMR Spectroscopy, John Wiley &Sons, Chichester
30. Ernst, R. R., Bodenhausen, G. and Wokaun, A. (1987) Principles of Nuclear Magnetic Resonance in One and Two Dimensions, Oxford University Press, New York
31. Sarles, L. R. and Cotts, R. M. (1958) Double nuclear magnetic resonance and the dipole interaction in solids. Physical Review, 111, pp. 853-859.
32. Bloch, F. (1958) Theory of line narrowing by double-frequency irradiation. Physical Review, 111, pp. 841-853.
33. Lowe, I. J. (1959) Free induction decays of rotating solids. Physical Review Letters, 2, pp. 285-287.
34. Andrew, E. R., Bradbury, A. and Eades, R. G. (1959) Removal of dipolar broadening of nuclear magnetic resonance spectra of solids by specimen rotation. Nature, 183, pp. 1802-1803.
35. Schaefer, J. and Stejskal, E. O. (1976) Carbon-13 nuclear magnetic resonance of polymers spinning at the magic angle. Journal of the American Chemical Society, 98, pp. 1031-1032.
36. Hartmann, S. R. and Hahn, E. L. (1962) Nuclear double resonance in the rotating frame. Physical Review, 128, pp. 2042-2053.
37. Opella, S. and Frey, M. H. (1979) Selection of nonprotonated carbon resonances in solid-state nuclear magnetic resonance. Journal of the American Chemical Society, 101, pp. 5854-5856.
38. Wu, X. L., Burns, S. T. and Zilm, K. W. (1994) Spectral Editing in CPMAS NMR. Generating subspectra based on proton multiplicities. Journal of Magnetic Resonance-Series A, 111, pp. 29-36.
39. 1H N.M.R. studies of solid polyolefines. Polymer, 26, pp. 169-176.
40. Sefcik, M. D., Schaefer, J., Stejskal, E. O. and McKay, R. A. (1980) Analysis of the room-temperature molecular motions of poly(ethylene terephthalate). Macromolecules, 13, pp. 1132-1137.
41. Gerstein, B. C., Pembleton, R. G., Wilson, L. C. and Ryan, L. M. (1977) High-resolution NMR in randomly oriented solids with homonuclear dipolar broadening: Combined multiple pulse NMR and magic angle spinning. The Journal of Chemical Physics, 66, pp. 361-362.
42. Brown, S. P. and Spiess, H. W. (2001) Advanced solid-state NMR methods for the elucidation of structure and dynamics of molecular, macromolecular and supramolecular systems. Chemical Reviews, 101, pp. 4125-4156.
43. Lesage, A., Sakellariou, D., Hediger, S., Eléna, B., Charmont, P., Steuernagel, S. and Emsley, L. (2003) Experimental aspects of proton NMR spectroscopy in solids using phase-modulated homonuclear dipolar decoupling. Journal of Magnetic Resonance, 163, pp. 105-113.
44. Burum, D. P. and Bielecki, A. (1991) An improved experiment for heteronuclear-correlation 2D NMR in solids. Journal of Magnetic Resonance, 94, pp. 645-652.
45. Caravatti, P., Bodenhausen, G. and Ernst, R. R. (1982) Heteronuclear solid-state correlation spectroscopy. Chemical Physics Letters, 89, pp. 363-367.
46. Caravatti, P., Braunschweiler, L. and Ernst, R. R. (1983) Heteronuclear correlation spectroscopy in rotating solids. Chemical Physics Letters, 100, pp. 305-310.
47. 13C NMR heteronuclear dipolar-correlation spectroscopy of solids with frequency-switched Lee-Goldburg homonuclear decoupling. Journal of Magnetic Resonance, 124, pp. 516-519.
48. 1H double-quantum CRAMPS NMR spectroscopy. Journal of the American Chemical Society, 126, pp. 13230-13231.
49. Lesage, A., Auger, C., Caldarelli, S. and Emsley, L. (1997) Determination of through-bond carbon-carbon connectivities in solid-state NMR using the INADEQUATE experiment. Journal of the American Chemical Society, 119, pp. 7867-7868.
50. Lesage, A., Bardet, M. and Emsley, L. (1999) Through-bond carbon-carbon connectivities in disordered solids by NMR. Journal of the American Chemical Society, 121, pp. 10987-10993.
51. Lesage, A., Sakellariou, D., Steuernagel, S. and Emsley, L. (1998) Carbon-proton chemical shift correlation in solid-state NMR by through-bond multiple-quantum spectroscopy. Journal of the American Chemical Society, 120, pp. 13194-13201.
52. Liu, S. -F., Mao, J. -D. and Schmidt-Rohr, K. (2002) A robust technique for two-dimensional separation of undistorted chemical-shift anisotropy powder patterns in magic-angle-spinning NMR. Journal of Magnetic Resonance, 155, pp. 15-28.
53. Kolbert, A. C. and Griffin, R. G. (1990) Two-dimensional resolution of isotropic and anisotropic chemical shifts in magic angle spinning NMR. Chemical Physics Letters, 166, pp. 87-91.
54. Alderman, D. W., George, G. Mc, Hu, J. Z., Pugmire, R. J. and Grant, D. M. (1998) A sensitive, high resolution magic angle turning experiment for measuring chemical shift tensor principal values. Molecular Physics, 95, pp. 1113-1126.
55. deLacroix, S. F., Titman, J. J., Hagemeyer, A. and Spiess, H. W. (1992) Increased resolution in MAS NMR spectra by two-dimensional separation of sidebands by order. Journal of Magnetic Resonance, 97, pp. 435-443.
56. Antzukin, O. N., Shekar, S. C. and Levitt, M. H. (1995) Two-dimensional sideband separation in magic-angle-spinning NMR. Journal of Magnetic Resonance, 115, pp. 7-19.
57. 15N-Chemical shift anisotropy of ampicillin and penicillin-V studied by 2D-PASS and CP/MAS NMR. Journal of Magnetic Resonance, 135, pp. 144-155.
58. Gullion, R. and Schaefer, J. (1989) Rotational-echo double-resonance NMR. Journal of Magnetic Resonance, 81, pp. 196-200.
59. Tycko, R. and Dabbagh, G. (1990) Measurement of nuclear magnetic dipole-dipole couplings in magic angle spinning NMR. Chemical Physics Letters, 173, pp. 461-465.
60. Bennett, A., Rienstra, C. M., Griffiths, J., Zhen, W., Lansbury, P. J. and Griffin, R. G. (1998) Homonuclear radio frequency-driven recoupling in rotating solids. The Journal of Chemical Physics, 108, pp. 9463-9479.
61. 13 dipolar recoupling under very fast magic angle spinning in solid-state nuclear magnetic resonance: Applications to distance measurements, spectral assignments, and high-throughput secondary-structure determination. Chemical Physics, 114, pp. 8473-8483.
62. Powles, J. G. and Strange, J. H. (1963) Zero time resolution nuclear magnetic resonance transient in solids. Proceedings of the Physical Society, 82, pp. 6-15.
63. U.S. Department of Health and Human Services (2007) Guidance for Industry-ANDAs: Pharmaceutical Solid Polymorphism Chemistry, Manufacturing, and Controls Information.Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, MD
64. Reutzel-Edens, S. M., Bush, J. K., Magee, P. A., Stephenson, G. A. and Byrn, S. R. (2003) Anhydrates and hydrates of olanzapine: Crystallization, solid-state characterization, and structural relationships. Crystal Growth &Design, 3, pp. 897-907.
65. Othman, A., Evans, J. S. O., Evans, I. Radosavljevic, Harris, R. K. and Hodgkinson, P. (2007) Structural study of polymorphs and solvates of finasteride. Journal of Pharmaceutical Sciences, 96, pp. 1380-1391.
66. Apperley, D. C., Forster, A. H., Fournier, R., Harris, R. K., Hodgkinson, P., Lancaster, R. W. and Rades, T. (2005) Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR. Magnetic Resonance in Chemistry, 43, pp. 881-892.
67. Schmidt, A. C. (2005) Solid-state characterization of falicaine hydrochloride and isomorphic dyclonine hydrochloride. Part IV. Crystal polymorphism of local anaesthetic drugs. European Journal of Pharmaceutical Sciences, 25, pp. 407-416.
68. Rubin-Preminger, J. M., Bernstein, J., Harris, R. K., Evans, I. Radosavljevic and Ghi, P. Y. (2004) Variable temperature studies of a polymorphic system comprising two pairs of enantiotropically related forms: [S,S]-Ethambutol dihydrochloride. Crystal Growth &Design, 4, pp. 431-439.
69. Sotthivirat, S., Lubach, J. W., Haslam, J. L., Munson, E. J. and Stella, V. J. (2007) Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy. Journal of Pharmaceutical Sciences, 96, pp. 1008-1017.
70. Lester, C., Lubey, G., Dicks, M., Andol, G., Vaughn, D., Cambron, R. T., Poiesz, K. and Redman-Furey, N. (2006) Dehydration of risedronate hemi-pentahydrate: Analytical and physical characterization. Journal of Pharmaceutical Sciences, 95, pp. 2631-2644.
71. Schmidt, A. C. and Schwarz, I. (2006) Solid-state characterization of non-stoichiometric hydrates of ester-type local anaesthetics Part XI. Crystal polymorphism of local anaesthetic drugs. International Journal of Pharmaceutics, 320, pp. 4-13.
72. Schmidt, A. C., Schwarz, I. and Mereiter, K. (2006) Polymorphism and pseudopolymorphism of salicaine and salicaine hydrochloride crystal polymorphism of local anaesthetic drugs, part V. Journal of Pharmaceutical Sciences, 95, pp. 1097-1113.
73. Redman-Furey, N., Dicks, M., Bigalow-Kern, A., Cambron, R. T., Lubey, G., Lester, C. and Vaughin, D. (2005) Structural and analytical characterization of three hydrates and an anhydrate form of risedronate. Journal of Pharmaceutical Sciences, 94, pp. 893-911.
74. 3 receptor antagonist, in both bulk and pharmaceutical dosage form samples. Drug Development and Industrial Pharmacy, 28, pp. 555-561.
75. Vogt, F. G., Cohen, D. E., Bowman, J. D., Spoors, G. P., Zuber, G. E., Trescher, G. A., Dell'Orco, P. C., Katrincic, L. M., Debrosse, C. W. and Haltiwanger, R. C. (2005) Structural analysis of polymorphism and solvation in tranilast. Journal of Pharmaceutical Sciences, 94, pp. 651-665.
76. Vogt, F. G., Dell'Orco, P. C., Diederich, A. M., Su, Q., Wood, J. L., Zuber, G. E., Katrincic, L. M., Mueller, R. L., Busby, D. J. and DeBrosse, C. W. (2006) A study of variable hydration states in topotecan hydrochloride. Journal of Pharmaceutical and Biomedical Analysis, 40, pp. 1080-1088.
77. Vogt, F. G., Brum, J., Katrinic, L. M., Flach, A., Socha, J. M., Goodman, R. M. and Haltiwanger, R. C. (2006) Physical, crystallographic, and spectroscopic characterization of a crystalline pharmaceutical hydrate: Understanding the role of water. Crystal Growth &Design, 6, pp. 2333-2354.
78. Apperley, D. C., Basford, P. A., Dallman, C. I., Harris, R. K., Kinns, M., Marshall, P. V. and Swanson, A. G. (2005) Nuclear magnetic resonance investigation of the interaction of water vapour with sildenafil citrate in the solid state. Journal of Pharmaceutical Sciences, 94, pp. 516-523.
79. Smith, J., MacNamara, E., Raftery, D., Borchardt, T. and Byrn, S. (1998) Application of two-dimensional 13C solid-state NMR to the study of conformational polymorphism. Journal of the American Chemical Society, 120, pp. 11710-11713.
80. Smith, J. R., Xu, W. and Raftery, D. (2006) Analysis of conformational polymorphism in pharmaceutical solids using solid-state NMR and electronic structure calculations. Journal of Physical Chemistry B, 110, pp. 7766-7776.
81. 13C NMR investigation of solid-state polymorphism in 10-deacetyl baccatin III. Journal of the American Chemical Society, 124, pp. 10589-10595.
82. Olejniczak, S. and Potrzebowski, M. J. (2004) Solid state NMR studies and density functional theory (DFT) calculations of conformers of quercetin. Organic and Biomolecular Chemistry, 2, pp. 2315-2322.
83. 15N solid-state NMR, together with shielding calculations. Magnetic Resonance in Chemistry, 42, pp. 313-320.
84. 31P CP/MAS NMR study on dehydration of disodium clodronate tetrahydrate. Pharmaceutical Research, 15, pp. 110-115.
85. Harris, R. K. (1985) Quantitative aspects of high-resolution solid-state nuclear magnetic resonance spectroscopy. Analyst, 110, pp. 649-655.
86. Bryce, D. L., Bernard, G. M., Gee, M., Lumsden, M. D., Eichele, K. and Wasylishen, R. E. (2001) Practical aspects of modern routine solid-state multinuclear magnetic resonance spectroscopy: One-dimensional experiments. Canadian Journal of Analytical Sciences and Spectroscopy, 46, pp. 46-82.
87. Stejskal, E. O., Schaefer, J., Sefcik, M. D. and McKay, R. A. (1981) Magic-angle carbon-13 nuclear magnetic resonance study of the compatibility of solid polymeric blends. Macromolecules, 14, pp. 275-279.
88. 15N NMR analysis of sildenafil base and citrate (Viagra) in solution, solid state and pharmaceutical dosage forms. Journal of Pharmaceutical and Biomedical Analysis, 38, pp. 865-870.
89. Harris, R. K., Hodgkinson, P., Larsson, T. and Muruganantham, A. (2005) Quantification of bambuterol hydrochloride in a formulated product using solid-state NMR. Journal of Pharmaceutical and Biomedical Analysis, 38, pp. 858-864.
90. Ziarelli, F. and Caldarelli, S. (2006) Solid-state NMR as an analytical tool: Quantitative aspects. Solid State Nuclear Magnetic Resonance, 29, pp. 214-218.
91. Suzuki, N. and Kawasaki, T. (2005) Evaluation of solid state form of troglitazone by solid state NMR spectroscopy. Journal of Pharmaceutical and Biomedical Analysis, 37, pp. 177-181.
92. Li, Z. J., Zell, M. T., Munson, E. J. and Grant, D. J. W. (1999) Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies. Journal of Pharmaceutical Sciences, 88, pp. 337-346.
93. 13CNMR of solid 2-aminobenzoic acid. Journal of Physics and Chemistry of Solids, 48, pp. 813-818.
94. Sheth, A. R., Lubach, J. W., Munson, E. J., Muller, F. X. and Grant, D. J. W. (2005) Mechanochromism of piroxicam accompanied by intermolecular proton transfer probed by spectroscopic methods and solid-phase changes. Journal of the American Chemical Society, 127, pp. 6641-6651.
95. Stephenson, G. A., Pfeiffer, R. and Byrn, S. R. (1997) Solid-state investigation of the tautomerism of acetohexamide. International Journal of Pharmaceutics, 146, pp. 93-99.
96. Bastin, R. J., Bowker, M. J. and Slater, B. J. (2000) Salt selection and optimisation procedures for pharmaceutical new chemical entities. Organic Process Research &Development, 4, pp. 427-435.
97. Geppi, M., Guccione, S., Mollica, G., Pignatello, R. and Veracini, C. A. (2005) Molecular properties of ibuprofen and its solid dispersions with Eudragit RL100 studied by solid-state nuclear magnetic resonance. Pharmaceutical Research, 22, pp. 1544-1555.
98. Harris, R. K., Cadars, S., Emsley, L., Yates, J. R., Pickard, C. J., Jetti, R. K. R. and Griesser, U. J. (2007) NMR crystallography of oxybuprocaine hydrochloride, Modification II°. Physical Chemistry Chemical Physics, 9, pp. 360-368.
99. Wolniak, M., Tomczyk, M., Gudej, J. and Wawer, I. (2006) Structural studies of methyl brevifolincarboxylate in solid state by means of NMR spectroscopy and DFT calculations. Journal of Molecular Structure, 825, pp. 26-31.
100. Harris, R. K., Ghi, P. Y., Hammond, R. B., Ma, C. -Y. and Roberts, K. J. (2003) Refinement of hydrogen atomic position in a hydrogen bond using a combination of solid-state NMR and computation. Chemical Communications, 22, pp. 2834-2835.
101. Wenslow, R. M., Baum, M. W., Ball, R. G., McCauley, J. A. and Varsolona, R. J. (2000) A spectroscopic and crystallographic study of polymorphism in an aza-steroid. Journal of Pharmaceutical Sciences, 89, pp. 1271-1285.
102. Harris, R. K. (2004) NMR crystallography: The use of chemical shifts. Solid State Sciences, 6, pp. 1025-1037.
103. Heider, E. M., Harper, J. K. and Grant, D. M. (2007) Structural characterization of an anhydrous polymorph of paclitaxel by solid-state NMR. Physical Chemistry Chemical Physics, 9, pp. 6083-6097.
104. Kaupp, M., Bühl, M. and Malkin, V. G. (2004) Calculation of NMR and EPR Parameters, Wiley-VCH Verlag GmbH &Co. KGaA, Weinheim
105. Pickard, C. J. and Mauri, F. (2001) All-electron magnetic response with pseudopotentials: NMR chemical shifts. Physical Review B, 63, p. 245101.
106. Harris, R. K., Ghi, P. Y., Pushmann, H., Apperley, D. C., Griesser, U. J., Hammond, R. B., Ma, C. -Y., Roberts, K. J., Pearce, G. J., Yates, J. R. and Pickard, C. J. (2005) Structural studies of the polymorphs of carbamazepine, its dihydrate, and two solvates. Organic Process Research &Development, 9, pp. 902-910.
107. Yates, J. R., Dobbins, S. E., Pickard, C. J., Mauri, F., Ghi, P. Y. and Harris, R. K. (2005) A combined first principles computational and solid-state NMR study of a molecular crystal: Flurbiprofen. Physical Chemistry Chemical Physics, 7, pp. 1402-1407.
108. Harris, R. K., Joyce, S. A., Pickard, C. J., Cadars, S. and Emsley, L. (2006) Assigning carbon-13 NMR spectra to crystal structures by the INADEQUATE pulse sequence and first principles computation: A case study of two forms of testosterone. Physical Chemistry Chemical Physics, 8, pp. 137-143.
109. Harris, R. K., Ghi, P. Y., Hammond, R. B., Ma, C. Y., Roberts, K. J., Yates, J. R. and Pickard, C. J. (2006) Solid-state NMR and computational studies of 4-methyl-2-nitroacetanilide. Magnetic Resonance in Chemistry, 44, pp. 325-333.
110. Mifsud, N., Elena, B., Pickard, C. J., Lesage, A. and Emsley, L. (2006) Assigning powders to crystal structures by high-resolution 1H-1H double quantum and 1H-13C J-INEPT solid-state NMR spectroscopy and first principles computation. A case study of penicillin G. Physical Chemistry Chemical Physics, 8, pp. 3418-3422.
111. 14N quadrupolar coupling: P-Aminosalicylic acid, isoniazid, and pyrazinamide. Journal of Physical Chemistry A, 106, pp. 11375-11379.
112. Schnell, I. (2004) Dipolar recoupling in fast-MAS solid-state NMR spectroscopy. Progress in Nuclear Magnetic Resonance Spectroscopy, 45, pp. 145-207.
113. Paik, Y., Yang, C., Metaferia, B., Tang, S., Bane, S., Ravindra, R., Shanker, N., Alcaraz, A. A., Johnson, S. A., Schaefer, J., O'Connor, R. D., Cegelski, L., Snyder, J. P. and Kingston, D. G. (2007) Rotational-echo double-resonance NMR distance measurements for the tubulin-bound paclitaxel conformation. Journal of the American Chemical Society, 129, pp. 361-370.
114. Mollica, G., Geppi, M., Pignatello, R. and Veracini, C. A. (2006) Molecular properties of flurbiprofen and its solid dispersions with Eudragit RL100 studied by high-and low-resolution solid-state nuclear magnetic resonance. Pharmaceutical Research, 23, pp. 2129-2140.
115. Zhang, G. G. Z., Gu, C., Zell, M. T., Burkhardt, R. T., Munson, E. J. and Grant, D. J. W. (2002) Crystallization and transitions of sulfamerazine polymorphs. Journal of Pharmaceutical Sciences, 91, pp. 1089-1099.
116. 13C solid-state NMR study of the structure and the dynamics of the polymorphs of sulphanilamide. Molecular Physics, 70, pp. 563-579.
117. Fattah, J., Twyman, J. M., Heyes, S. J., Watkin, D. J., Edwards, A. J., Prout, K. and Dobson, C. M. (1993) Combination of CP/MAS NMR and X-ray crystallography: Structure and dynamics in a low-symmetry molecular crystal, potassium penicillin V. Journal of the American Chemical Society, 115, pp. 5636-5650.
118. 13C NMR and crystallographic stereochemical study. Journal of Organic Chemistry, 65, pp. 6345-6353.
119. Stephenson, G. A., Stowell, J. G., Toma, P. H., Dorman, D. E., Green, J. R. and Byrn, S. R. (1994) Solid-state analysis of polymorphic, isomorphic, and solvated forms of dirithromycin. Journal of the American Chemical Society, 116, pp. 5766-5773.
120. 13C CP/MAS NMR. Pharmaceutical Research, 15, pp. 1425-1433.
121. 1H NMR relaxation times. Journal of Pharmaceutical Sciences, 89, pp. 408-416.
122. Forster, A., Apperley, D., Hempenstall, J., Lancaster, R. and Rades, T. (2003) Investigation of the physical stability of amorphous drug and drug/polymer melts using variable temperature solid state NMR. Pharmazie, 58, pp. 761-762.
123. 13C NMR. International Journal of Pharmaceutics, 275, pp. 73-83.
124. Masuda, K., Tabata, S., Sakata, Y., Hayase, T., Yonemochi, E. and Terada, K. (2005) Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times. Pharmaceutical Research, 22, pp. 797-805.
125. Wheatley, T. A. (2000) What are excipients?. Excipient Toxicity and Safety, Drugs, pp. 1-20. Marcel Dekker, New York
126. Leung, S., Padden, B. E., Munson, E. J. and Grant, D. J. W. (1998) Solid-state characterization of two polymorphs of aspartame hemihydrate. Journal of Pharmaceutical Sciences, 87, pp. 501-507.
127. Leung, S., Padden, B. E., Munson, E. J. and Grant, D. J. W. (1998) Hydration and dehydration behavior of aspartame hemihydrate. Journal of Pharmaceutical Sciences, 87, pp. 508-513.
128. 13C-labeled aspartame. Journal of the American Chemical Society, 121, pp. 1372-1378.
129. Zell, M. T., Padden, B. E., Grant, D. J. W., Schroeder, S. A., Wachholder, K. L., Prakash, I. and Munson, E. J. (2000) Investigation of polymorphism in aspartame and neotame using solid-state NMR spectroscopy. Tetrahedron, 56, pp. 6603-6616.
130. 13C NMR spectroscopy and powder X-ray diffraction for analyzing mixtures of polymorphs of neotame. Analytical Chemistry, 71, pp. 3325-3331.
131. 13C-NMR chemical shifts of carbohydrates in the solid state. The spectra of -mannitol polymorphs and -mannitol. Carbohydrate Research, 197, pp. 41-52.
132. Yoshinari, T., Forbes, R. T., York, P. and Kawashima, Y. (2002) Moisture induced polymorphic transition of mannitol and its morphological transformation. International Journal of Pharmaceutics, 247, pp. 69-77.
133. 13C NMR spectroscopy. Carbohydrate Research, 342, pp. 1525-1529.
134. Bail, P. Le, Morin, F. G. and Marchessault, R. H. (1999) Characterization of a crosslinked high amylose starch excipient. International Journal of Biological Macromolecules, 26, pp. 193-200.
135. 1 relaxation of epichloroidrin crosslinked high amylose starch excipient. Starch/ Stärke, 52, pp. 186-195.
136. Lenaerts, V., Moussa, I., Dumoulin, Y., Mebsout, F., Chouinard, F., Szabo, P., Mateescu, M. A., Cartilier, L. and Marchessault, R. (1998) Cross-linked high amylose starch for controlled release of drugs: Recent advances. Journal of Controlled Release, 53, pp. 225-234.
137. Li, B., O'Meara, M. H., Lubach, J. W., Schowen, R. L., Topp, E. M., Munson, E. J. and Borchardt, R. T. (2005) Effects of sucrose and mannitol on asparagines deamidation rates of model peptides in solution and in the solid state. Journal of Pharmaceutical Sciences, 94, pp. 1723-1735.
138. Lubach, J. W., Xu, D., Degmuller, B. E. and Munson, E. J. (2007) Investigation of the effects of pharmaceutical processing upon solid-state NMR relaxation times and implications to solid-state formulation stability. Journal of Pharmaceutical Sciences, 96, pp. 777-787.
139. Gustafsson, C., Lenhholm, H., Iversen, T. and Nyström, C. (1998) Comparison of solid-state NMR and isothermal microcalorimetry in the assessment of the amorphous component of lactose. International Journal of Pharmaceutics, 174, pp. 243-252.
140. Lefort, R., de Gusseme, A., Willart, J. -F., Danède, F. and Descamps, M. (2004) Solid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: An application to ball-milling of trehalose. International Journal of Pharmaceutics, 280, pp. 209-219.
141. 13C CPMAS NMR spectroscopy. Journal of Pharmaceutical Sciences, 94, pp. 2591-2605.
142. Vervoort, L., Mooter, G. Van den, Augustijns, P., Busson, R., Toppet, S. and Kinget, R. (1997) Inulin hydrogels as carriers for colonic drug targeting: I. Synthesis and characterization of methacrylated inulin and hydrogel formation. Pharmaceutical Research, 14, pp. 1730-1737.
143. Pouyani, T., Harbison, G. S. and Prestwich, G. D. (1994) Novel hydrogels of hyaluronic acid: Synthesis, surface morphology, and solid state NMR. Journal of the American Chemical Society, 116, pp. 7515-7522.
144. 13C chemical shifts. Macromolecules, 20, pp. 2424-2430.
145. Raymond, L., Morin, F. G. and Marchessault, R. H. (1993) Degree of deacetylation of chitosan using conductometric titration and solid-state NMR. Carbohydrate Research, 246, pp. 331-336.
146. Heux, L., Brugnerotto, J., Desbrières, J., Versali, M. F. and Rinaudo, M. (2000) Solid state NMR for the determination of degree of acetylation of chitin and chitosan. Biomacromolecules, 1, pp. 746-751.
147. Nunthanid, J., Laungtana-anan, M., Sriamorsnak, P., Limmatvapirat, S., Puttipipatkhachorn, S., Lim, L. Y. and Khor, E. (2004) Characterization of chitosan acetate as a binder for sustained release tablets. Journal of Controlled Release, 99, pp. 15-26.
148. Ravenelle, F. and Rahmouni, M. (2006) Contramid®: High-amylose starch for controlled drug delivery. Polysaccharides for Drug-Delivery and Pharmaceutical Applications, pp. 79-104. Oxford University Press, USA
149. 2 matrices prepared at protein-compatible pH. Journal of Non-Crystalline Solids, 351, pp. 3225-3234.
150. Colo, G. Di, Baggiani, A., Zambito, Y., Mollica, G., Geppi, M. and Serafini, M. F. (2006) A new hydrogel for the extended and complete release in the GI tract. International Journal of Pharmaceutics, 310, pp. 154-161.
151. Moribe, K., Sekiya, N., Fujito, T., Yamamoto, M., Higashi, K., Yokohama, C., Tozuka, Y. and Yamamoto, K. (2007) Stabilization mechanism of limaprost in solid dosage form. International Journal of Pharmaceutics, 338, pp. 1-6.
152. Yoshioka, S., Aso, Y. and Kojima, S. (1997) Dependence of the molecular mobility and protein stability of freeze-dried γ-globulin formulations on the molecular weight of dextran. Pharmaceutical Research, 14, pp. 736-741.
153. Yoshioka, S., Aso, Y., Nakai, Y. and Kojima, S. (1998) Effect of high molecular mobility of poly(vinyl alcohol) on protein stability of lyophilized γ-globulin formulations. Journal of Pharmaceutical Sciences, 87, pp. 147-151.
154. Yoshioka, S., Aso, Y. and Kojima, S. (1999) The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature. Pharmaceutical Research, 16, pp. 135-140.
155. Yoshioka, S. and Aso, Y. (2005) Glass transition-related changes in molecular mobility below glass transition temperature of freeze-dried formulations, as measured by dielectric spectroscopy and solid-state nuclear magnetic resonance. Journal of Pharmaceutical Sciences, 94, pp. 275-287.
156. 13C solid-state NMR. Pharmaceutical Research, 16, pp. 1621-1625.
157. Yoshioka, S., Aso, Y. and Kojima, S. (2002) Different molecular motions in lyophilized protein formulations as determined by laboratory and rotating-frame spin-lattice relaxation times. Journal of Pharmaceutical Sciences, 91, pp. 2203-2210.
158. 13C. Chemical & Pharmaceutical Bulletin, 51, pp. 1289-1292.
159. Lam, Y. -H., Bustami, R., Phan, T., Chan, H. -K. and Separovic, F. (2002) A solid-state NMR study of protein mobility in lyophilized protein-sugar powders. Journal of Pharmaceutical Sciences, 91, pp. 943-951.
160. Lowman, A. M., Cowans, B. A. and Peppas, N. A. (2000) Investigation of interpolymer complexation in swollen polyelectrolyte networks using solid-state NMR spectroscopy. Journal of Polymer Science Part B: Polymer Physics, 38, pp. 2823-2831.
161. Colo, G. Di, Zaino, C., Zambito, Y., Mollica, G., Geppi, M., Serafini, M. F. and Carelli, V. (2007) A novel polyelectrolyte complex (PEC) hydrogel for controlled drug delivery to the distal intestine. The Open Drug Delivery Journal, 1, pp. 68-75.
162. 13C-NMR relaxation times. Chemical & Pharmaceutical Bulletin, 50, pp. 822-826.
163. Nakama, T., Ooya, T. and Yui, N. (2004) Temperature-and pH-controlled hydrogelation of poly(ethylene glycol)-grafted hyaluronic acid by inclusion complexation with α-cyclodextrin. Polymer Journal, 36, pp. 338-344.
164. Bibby, D. C., Davies, N. M. and Tucker, I. G. (1999) Investigations into the structure and composition of β-cyclodextrin/poly(acrylic acid) microspheres. International Journal of Pharmaceutics, 180, pp. 161-168.
165. Wang, L. -F., Chen, W. B., Chen, T. -Y. and Lu, S. C. (2003) Effects of the preaparation methods of hydroxypropyl methylcellulose/polyacrylic acid blended films on drug release. Journal of Biomaterials Science, Polymer Edition, 14, pp. 27-44.
166. Remenar, J. F., Wenslow, R., Ostovic, D. and Peresypkin, A. (2004) Solid-state nuclear magnetic resonance determination of the physical form of BHA on common pharmaceutical excipients. Pharmaceutical Research, 21, pp. 185-188.
167. Ameye, D., Pringels, E., Foreman, P., Remon, J. P., Adriaensens, P., Storme, L. and Gelan, J. (2005) Correlation between the molecular morphology and the biocompatibility of bioadhesive carriers prepared from spray-dried starch/Carbopol® blends. Polymer, 46, pp. 2338-2345.
168. Dukic, A., Mens, R., Adriaensens, P., Foreman, P., Gelan, J., Remon, J. P. and Vervaet, C. (2007) Development of starch-based pellets via extrusion/spheronization. European Journal of Pharmaceutics and Biopharmaceutics, 66, pp. 83-94.
169. Saindon, P. J., Cauchon, N. S., Sutton, P. A., Chang, C. -J., Peck, G. E. and Byrn, S. R. (1993) Solid-state Nuclear Magnetic Resonance (NMR) spectra of pharmaceutical dosage forms. Pharmaceutical Research, 10, pp. 197-203.
170. Schachter, D. M., Xiong, J. and Tirol, G. C. (2004) Solid state NMR perspective of drug-polymer solid solutions: A model system based on poly(ethylene oxide). International Journal of Pharmaceutics, 281, pp. 89-101.
171. Markovich, R. J., Evans, C. Anderson, Coscolluela, C. B., Zibas, S. A. and Rosen, J. (1997) Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation. Journal of Pharmaceutical and Biomedical Analysis, 16, pp. 661-673.
172. Lubach, J. W., Padden, B. E., Winslow, S. L., Salsbury, J. S., Masters, D. B., Topp, E. M. and Munson, E. J. (2004) Solid-state NMR studies of pharmaceutical solids in polymer matrices. Analytical and Bioanalytical Chemistry, 378, pp. 1504-1510.
173. Rohrs, B. R., Thamann, T. J., Gao, P., Stelzer, D. J., Bergren, M. S. and Chao, R. S. (1999) Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant. Pharmaceutical Research, 16, pp. 1850-1856.
174. 13C solid-state CPMAS NMR to study polymorphism in low dose solid formulations. Journal of Pharmaceutical Sciences, 94, pp. 458-463.
175. Suihko, E. J., Forbes, R. T. and Apperley, D. C. (2005) A solid-state NMR study of molecular mobility and phase separation in co-spray-dried protein-sugar particles. European Journal of Pharmaceutical Sciences, 25, pp. 105-112.
176. Griffin, J. M., Martin, D. R. and Brown, S. P. (2007) Distinguishing anhydrous and hydrous forms of an active pharmaceutical ingredient in a tablet formulation using solid-state NMR spectroscopy. Angewandte Chemie International Edition, 46, pp. 8036-8038.
177. 13C solid state NMR. International Journal of Pharmaceutics, 248, pp. 123-129.
178. Barich, D. H., Davis, J. M., Schieber, L. J., Zell, M. T. and Munson, E. J. (2006) Investigation of solid-state NMR line widths of ibuprofen in drug formulations. Journal of Pharmaceutical Sciences, 95, pp. 1586-1594.
179. Pignatello, R., Ferro, M., de Guidi, G., Salemi, G., Vandelli, M. A., Guccione, S., Geppi, M., Forte, C. and Puglisi, G. (2001) Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100® and RL100®. International Journal of Pharmaceutics, 218, pp. 27-42.
180. 13C solid state NMR to elucidate physico-chemical association in Eudragit® RS100 microencapsulated acyl esters of salicylic acid. European Journal of Pharmaceutics and Biopharmaceutics, 45, pp. 9-21.
181. Aldén, M., Lydén, M. and Tegenfeldt, J. (1994) Effect of counterions on the interactions in solid dispersions between polyethylene glycol, griseofulvin and alkali dodecyl sulphates. International Journal of Pharmaceutics, 110, pp. 267-276.
182. Pongpeerapat, A., Higashi, K., Tozuka, Y., Moribe, K. and Yamamoto, K. (2006) Molecular interactions among probucol/PVP/SDS multicomponent system investigated by solid-state NMR. Pharmaceutical Research, 23, pp. 2566-2574.
183. 13C-NMR spin-lattice relaxation time. Journal of Pharmaceutical Sciences, 95, pp. 318-325.
184. Chen, J. -Z., Ranade, S. V. and Xie, X. -Q. (2005) NMR characterization of paclitaxel/poly (styrene-isobutylene-styrene) formulations. International Journal of Pharmaceutics, 305, pp. 129-144.
185. Potrzebowski, M. J. and Kazmierski, S. (2004) High-resolution solid-state NMR studies of inclusion complexes. Topics in Current Chemistry, 246, pp. 91-140.
186. Braga, S. S., Gonçalves, I. S., Herdtweck, E. and Teixeira-Dias, J. J. C. (2003) Solid state inclusion compound of S-ibuprofen in β-cyclodextrin: Structure and characterisation. New Journal of Chemistry, 27, pp. 597-601.
187. 2) in 2-hydroxypropyl-and trimethyl-β-cyclodextrin: Structural and biological properties. Journal of Organometallic Chemistry, 690, pp. 2905-2912.
188. Morin, N., Crini, G., Cosentino, C., Millet, J., Vebrel, J. and Rouland, J. -C. (1999) Formation of two particular structures between β-cyclodextrin and bifonazole: β-cyclodextrin-bifonazole and (β-cyclodextrin)i-bifonazole (where 2 < i < 3). Journal of the Chemical Society, Perkin Transactions, 2, pp. 2647-2651.
189. Wulff, M., Aldén, M. and Tegenfeldt, J. (2002) Solid-state NMR investigation of indomethacin-cyclodextrin complexes in PEG 6000 carrier. Bioconjugate Chemistry, 13, pp. 240-248.
190. 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-α-and-β-cyclodextrins. Pharmaceutical Research, 16, pp. 1729-1734.
191. Azaïs, T., Tourné-Péteilh, C., Aussenac, F., Baccile, N., Coelho, C., Devoisselle, J. -M. and Babonneau, F. (2006) Solid-state NMR study of ibuprofen confined in MCM-41 material. Chemistry of Materials, 18, pp. 6382-6390.
192. Geppi, M., Mollica, G. and Borsacchi, S.
193. Babonneau, F., Yeung, L., Steunou, N., Gervais, C., Ramila, A. and Vallet-Regi, M. (2004) Solid state NMR characterisation of encapsulated molecules in mesoporous silica. Journal of Sol-Gel Science and Technology, 31, pp. 219-223.
194. Puttipipatkhachorn, S., Nunthanid, J., Yamamoto, K. and Peck, G. E. (2001) Drug physical state and drug-polymer interaction on drug release from chitosan matrix films. Journal of Controlled Release, 75, pp. 143-153.
195. Wissing, S. A., Müller, R. H., Manthei, L. and Mayer, C. (2004) Structural characterization of Q10-loaded solid lipid nanoparticles by NMR spectroscopy. Pharmaceutical Research, 21, pp. 400-405.
196. Chen, X., Griesser, U. J., Te, R. L., Pfeiffer, R. R., Morris, K. R., Stowell, J. G. and Byrn, S. R. (2005) Analysis of the acid-base reaction between solid indomethacin and sodium bicarbonate using infrared spectroscopy, X-ray powder diffraction, and solid-state nuclear magnetic resonance spectroscopy. Journal of Pharmaceutical and Biomedical Analysis, 38, pp. 670-677.
197. Byrn, S. R., Xu, W. and Newman, A. W. (2001) Chemical reactivity in solid-state pharmaceuticals: Formulation implications. Advanced Drug Delivery Reviews, 48, pp. 115-136.
198. Zhu, L., Kumar, V. and Banker, G. S. (2001) Examination of oxidized cellulose as a macromolecular prodrug carrier: Preparation and characterization of an oxidized cellulose-phenylpropanolamine conjugate. International Journal of Pharmaceutics, 223, pp. 35-47.
199. 13C NMR studies on conformational polymorphism in sertraline hydrochloride, an antidepressant drug. Magnetic Resonance in Chemistry, 40, pp. 723-728.
200. Harris, R. K., Kenwright, A. M., Fletton, R. A. and Lancaster, R. W. (1998) NMR and polymorphism of a steroidal anaesthetic. Spectrochimica Acta, Part A, 54, pp. 1837-1847.
201. Li, R., Mayer, T., Trivedi, J. S. and Fort, J. J. (1996) Polymorphism and crystallization behavior of Abbott-79175, a second-generation 5-lipoxygenase inhibitor. Journal of Pharmaceutical Sciences, 85, pp. 773-780.
202. Stephenson, G. A. (2000) Structure determination from conventional powder diffraction data: Application to hydrates, hydrochloride salts, and metastable polymorphs. Journal of Pharmaceutical Sciences, 89, pp. 958-966.
203. 13C nuclear magnetic resonance study of the conformational states of penicillins. Journal of the Chemical Society, Perkin Transactions, 2, pp. 1933-1940.
204. Wang, Y., Wenslow, R. M., McCauley, J. A. and Crocker, L. S. (2002) Polymorphic behavior of an NK1 receptor antagonist. International Journal of Pharmaceutics, 243, pp. 147-159.
205. Harris, R. K., Say, B. J., Yeung, R. R., Fletton, R. A. and Lancaster, R. W. (1989) Cross-polarization/magic-angle spinning NMR studies of polymorphism: Androstanolone. Spectrochimica Acta, Part A, 45, pp. 465-469.
206. Byrn, S. R., Gray, G., Pfeiffer, R. R. and Frye, J. (1985) Analysis of solid-state carbon-13 NMR spectra of polymorphs (benoxaprofen and nabilone) and pseudopolymorphs (cefazolin). Journal of Pharmaceutical Sciences, 74, pp. 565-568.
207. Sheikhzadeh, M., Rohani, S., Jutan, A. and Manifar, T. (2007) Quantitative and molecular analysis of buspirone hydrochloride polymorphs. Journal of Pharmaceutical Sciences, 96, pp. 569-583.
208. Matsunaga, H., Eguchi, T., Nishijima, K., Enomoto, T., Sasaoki, K. and Nakamura, N. (1999) Solid-state characterization of candesartan cilexetil (TCV-116): Crystal structure and molecular mobility. Chemical and Pharmaceutical Bulletin, 47, pp. 182-186.
209. McMahon, E., Timmins, P., Williams, A. C. and York, P. (1996) Characterization of dihydrates prepared from carbamazepine polymorphs. Journal of Pharmaceutical Sciences, 85, pp. 1064-1069.
210. 2O) in a mixture by solid-state nuclear magnetic resonance (NMR). Pharmaceutical Research, 7, pp. 184-187.
211. Singh, D., Marshall, P. V., Shields, L. and York, P. (1998) Solid-state characterization of chlordiazepoxide polymorphs. Journal of Pharmaceutical Sciences, 87, pp. 655-662.
212. 13C NMR characterization of the stable solid-state forms of cimetidine. Journal of Pharmaceutical Sciences, 86, pp. 1400-1402.
213. 13C solid-state NMR distance and angle measurements. Journal of the American Chemical Society, 122, pp. 1161-1170.
214. Hanai, K., Kuwae, A., Senda, H. and Kunimoto, K. -K. (2001) A comparative vibrational and NMR study of cis-cinnamic acid polymorphs and trans-cinnamic acid. Spectrochimica Acta, Part A, 57, pp. 513-519.
215. Tozuka, Y., Ito, A., Seki, H., Oguchi, T. and Yamamoto, K. Y. (2002) Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy. Chemical and Pharmaceutical Bulletin, 50, pp. 1128-1130.
216. 13C resonances for polymorphs of cortisone acetate using shielding tensor components. Solid State Nuclear Magnetic Resonance, 1, pp. 93-101.
217. Harris, R. K., Kenwright, A. M., Say, B. J., Yeung, R. R., Fletton, R. A., Lancaster, R. W. and Hardgrove Jr., G. L. (1990) Cross-polarization/ magic-angle spinning NMR studies of polymorphism: Cortisone acetate. Spectrochimica Acta, Part A, 46, pp. 927-935.
218. Gerber, J. J., van der Watt, J. G. and Lotter, A. P. (1991) Physical characterisation of solid forms of cyclopenthiazide. International Journal of Pharmaceutics, 73, pp. 137-145.
219. 13C CP/MAS NMR. Pharmaceutical Research, 13, pp. 1095-1104.
220. Vrbinc, M., Jordan-Kotar, B., Smrkolj, M. and Vrecer, F. (2007) Characterization of physical forms of donepezil hydrochloride. Acta Chimica Slovenica, 54, pp. 254-267.
221. Ribet, J. P., Pena, R., Chauvet, A., Patoiseau, J. F., Autin, J. M., Segonds, R., Basquin, M. and Autret, J. M. (2002) Crystalline polymorphism of eflucimibe. Ann. Pharm. Fr., 60, pp. 177-186.
222. Ip, D. P., Brenner, G. S., Stevenson, J. M., Lindebaum, S., Douglas, A. W., Klein, S. K. and McCauley, J. A. (1986) High resolution spectroscopic evidence and solution calorimetry studies on the polymorphs of enalapril maleate. International Journal of Pharmaceutics, 28, pp. 183-191.
223. Stephenson, G. A., Stowell, J. G., Toma, P. H., Pfeiffer, R. R. and Byrn, S. R. (1997) Solid-state investigations of erythromycin A dihydrate: Structure, NMR spectroscopy, and hygroscopicity. Journal of Pharmaceutical Sciences, 86, pp. 1239-1244.
224. Iuliucci, R. J., Clawson, J., Hu, J. Z., Solum, M. S., Barich, D., Grant, D. M. and Taylor, C. M. V. (2003) Ring-chain tautomerism in solid-phase erythromycin A: Evidence by solid-state NMR. Solid State Nuclear Magnetic Resonance, 24, pp. 23-38.
225. Srcic, S., Kerc, J., Urleb, U., Zupancic, I., Lahajnar, G., Kofler, B. and Smid-Korbar, J. (1992) Investigation of felodipine polymorphism and its glassy state. International Journal of Pharmaceutics, 87, pp. 1-10.
226. Apperley, D. C., Harris, R. K., Larsson, T. and Malmstron, T. (2003) Quantitative nuclear magnetic resonance analysis of solid formoterol fumarate and its dihydrate. Journal of Pharmaceutical Sciences, 92, pp. 2496-2503.
227. Brittain, H. G., Morris, R. K., Bugay, D. E., Thakur, A. B. and Scrajuddin, A. T. M. (1993) Solid-state NMR and IR for the analysis of pharmaceutical solids: Polymorphs of fosinopril sodium. Journal of Pharmaceutical and Biomedical Analysis, 11, pp. 1063-1069.
228. Rychlewska, U., Budesinsky, M., Szezepanska, B., Bloszyk, E. and Holub, M. (1995) Two crystalline forms of sesquiterpene lactone helenalin-X-ray and NMR study. Collection of Czechoslovak Chemical Communications, 60, pp. 276-299.
229. 13C NMR to the study of polymorphs, clathrates and complexes. Chemical Physics Letters, 74, pp. 536-538.
230. Schmidt, A. C. and Schwarz, I. (2005) Solid state characterization of hydroxyprocaine hydrochloride. Crystal polymorphism of local anaesthetic drugs, part VIII. Journal of Molecular Structure, 748, pp. 153-160.
231. Schmidt, A. C. (2005) The role of molecular structure in the crystal polymorphism of local anesthetic drugs: Crystal polymorphism of local anesthetic drugs, part X. Pharmaceutical Research, 22, pp. 2121-2133.
232. Lin, S. -Y. (1992) Isolation and solid-state characteristics of a new crystal form of indomethacin. Journal of Pharmaceutical Sciences, 81, pp. 572-576.
233. Watanabe, T., Wakiyama, N., Usui, F., Ikeda, M., Isobe, T. and Senna, M. (2001) Stability of amorphous indomethacin compounded with silica. International Journal of Pharmaceutics, 226, pp. 81-91.
234. Bauer, M., Harris, R. K., Rao, R. C., Apperley, D. C. and Rodger, C. A. (1998) NMR study of desmotropy in Irbesartan, a tetrazole-containing pharmaceutical compound. Journal of the Chemical Society, Perkin Transactions, 2, pp. 475-481.
235. 4 receptor antagonist. Pharmaceutical Research, 8, pp. 148-155.
236. Harris, R. K., Yeung, R. R., Lamont, R. B., Lancaster, R. W., Lynn, S. M. and Staniforth, S. E. (1997) "Polymorphism" in a novel anti-viral agent: Lamivudine. Journal of the Chemical Society, Perkin Transactions, 2, pp. 2653-2659.
237. Reutzel, S. M. and Russell, V. A. (1998) Origins of the unusual hygroscopicity observed in LY297802 tartrate. Journal of Pharmaceutical Sciences, 87, pp. 1568-1571.
238. Reutzel-Edens, S. M., Kleemann, R. L., Lewellen, P. L., Borghese, A. L. and Antoine, L. J. (2003) Crystal forms of LY334370 HCl: Isolation, solid-state characterization and physicochemical properties. Journal of Pharmaceutical Sciences, 92, pp. 1196-1205.
239. Zhu, H., Halfen, J. A., Young Jr., V. G., Padden, B. E., Munson, E. J., Menon, V. and Grant, D. J. W. (1997) Physicochemical characterization of nedocromil bivalent metal salt hydrates. 3. Nedocromil calcium. Journal of Pharmaceutical Sciences, 86, pp. 1439-1447.
240. Zhu, H., Khankari, R. K., Padden, B. E., Munson, E. J., Gleason, W. B. and Grant, D. J. W. (1996) Physicochemical characterization of nedocromil bivalent metal salt hydrates. 1. Nedocromil magnesium. Journal of Pharmaceutical Sciences, 85, pp. 1026-1034.
241. Zhu, H. and Grant, D. J. W. (2001) Dehydration behavior of nedocromil magnesium pentahydrate. International Journal of Pharmaceutics, 215, pp. 251-262.
242. Chen, L. R., Padden, B. E., Vippagunta, S. R., Munson, E. J. and Grant, D. J. W. (2000) Nuclear magnetic resonance and infrared spectroscopic analysis of nedocromil hydrates. Pharmaceutical Research, 17, pp. 619-624.
243. Zhu, H., Padden, B. E., Munson, E. J. and Grant, D. J. W. (1997) Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc. Journal of Pharmaceutical Sciences, 86, pp. 418-429.
244. Stoltz, M., Oliver, D. W., Wessels, P. L. and Chalmers, A. A. (1991) High-resolution solid-state carbon-13 nuclear magnetic resonance spectra of mofebutazone, phenylbutazone, and oxyphenbutazone in relation to X-ray crystallographic data. Journal of Pharmaceutical Sciences, 80, pp. 357-362.
245. Lee, J. H., Gi, U. -S., Kim, J. -H., Kim, Y., Kim, S. -H., Oh, H. and Min, B. (2001) Preparation and characterization of solvent induced dihydrated, anhydrous, and amorphous paclitaxel. Bulletin of the Korean Chemical Society, 22, pp. 925-928.
246. Byrn, S. R., Sutton, P. A., Tobias, B., Frye, J. and Main, P. (1988) The crystal structure, solid-state NMR spectra, and oxygen reactivity of five crystal forms of prednisolone tert-butylacetate. Journal of the American Chemical Society, 110, pp. 1609-1614.
247. Giordano, F., Rossi, A., Moyano, J. R., Gazzaniga, A., Massarotti, V., Bini, M., Capsoni, D., Peveri, T., Redenti, E., Carima, L., Alberi, M. Dagli and Zanol, M. (2001) Polymorphism of rac-5,6-diisobutyryloxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene hydrochloride (CHF 1035). I. Thermal, spectroscopic, and X-ray diffraction properties. Journal of Pharmaceutical Sciences, 90, pp. 1154-1163.
248. Chieng, N., Zujovic, Z., Bowmaker, G., Rades, T. and Saville, D. (2006) Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1. International Journal of Pharmaceutics, 327, pp. 36-44.
249. Agrawal, S., Ashokraj, Y., Bharatam, P. V., Pillai, O. and Panchagnula, R. (2004) Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. European Journal of Pharmaceutical Sciences, 22, pp. 127-144.
250. Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W. and Morris, J. (2001) Ritonavir: An extraordinary example of conformational polymorphism. Pharmaceutical Research, 18, pp. 859-866.
251. Vickery, R. D., Nemeth, G. A. and Maurin, M. B. (2002) Solid-state carbon NMR characterization of the polymorphs of roxifiban. Journal of Pharmaceutical and Biomedical Analysis, 30, pp. 125-129.
252. Maurin, M. B., Vickery, R. D., Rabel, S. R., Rowe, S. M., Everlof, J. G., Nemeth, G. A., Campbell, G. C. and Foris, C. M. (2002) Polymorphism of roxifiban. Journal of Pharmaceutical Sciences, 91, pp. 2599-2604.
253. Glaser, R., Shiftan, D. and Drouin, M. (1999) Conformational pseudopolymorphism and solid-state CPMAS NMR studies for determination of solvent-dependent solution-state conformational preferences for (-)-scopolamine hydrobromide/hydrochloride salts. Journal of Organic Chemistry, 64, pp. 9217-9224.
254. Glaser, R., Shiftan, D. and Drouin, M. (2000) The solid-state structures of (-) scopolamine free base, (-)-scopolamine methobromide, (-)-scopolamine hydrobromide trihydrate, and of the pseudopolymorphic forms of (-)-scopolamine hydrochloride anhydrate and 1.66 hydrate. Canadian Journal of Chemistry, 78, pp. 212-223.
255. Martino, P. Di, Barthélémy, C., Joiris, E., Capsoni, D., Masic, A., Massarotti, V., Gobetto, R., Bini, M. and Martelli, S. (2007) A new tetrahydrated form of sodium naproxen. Journal of Pharmaceutical Sciences, 96, pp. 156-167.
256. Morris, K. R., Newman, A. W., Bugay, D. E., Ranadive, S. A., Singh, A. K., Szyper, M., Varia, S. A., Brittain, H. G. and Scrajuddin, A. T. M. (1994) Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development. International Journal of Pharmaceutics, 108, pp. 195-206.
257. Apperley, D. C., Fletton, R. A., Harris, R. K., Lancaster, R. W., Tavener, S. and Threlfall, T. L. (1999) Sulphathiazole polymorphism studied by magic-angle spinning NMR. Journal of Pharmaceutical Sciences, 88, pp. 1275-1280.
258. Anwar, J., Tarling, S. E. and Barnes, P. (1989) Polymorphism of sulphathiazole. Journal of Pharmaceutical Sciences, 78, pp. 337-342.
259. Kimura, N., Fukui, H., Takagaki, H., Yonemochi, E. and Terada, K. (2001) Characterization of polymorphs of a novel quinolinone derivative, TA-270 (4-hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone). Chemical & Pharmaceutical Bulletin, 49, pp. 1321-1325.
260. Fletton, R. A., Harris, R. K., Kenwright, A. M., Lancaster, R. W., Packer, K. J. and Sheppard, N. (1987) A comparative spectroscopic investigation of three pseudopolymorphs of testosterone using solid-state I.R. and high-resolution solid-state NMR. Spectrochimica Acta, Part A, 43, pp. 1111-1120.
261. Te, R. L., Griesser, U. J., Morris, K. R., Byrn, S. R. and Stowell, J. G. (2003) X-ray diffraction and solid-state NMR investigation of the single-crystal to single-crystal dehydration of thiamine hydrochloride monohydrate. Crystal Growth & Design, 3, pp. 997-1004.
262. Kimura, K., Hirayama, F. and Uekama, K. (1999) Characterization of tolbutamide polymorphic transition behavior. Journal of Pharmaceutical Sciences, 88, pp. 385-391.
263. Variankaval, N. E., Jacob, K. I. and Dinh, S. M. (2000) Characterization of crystal forms of β-estradiol - Thermal analysis, Raman microscopy, X-ray analysis and solid-state NMR. Journal of Crystal Growth, 217, pp. 320-331.
264. Park, J. -S., Kang, H. W., Park, S. J. and Kim, C. -K. (2005) Use of CP/ MAS solid-state NMR for the characterization of solvate molecules within estradiol crystal forms. European Journal of Pharmaceutics and Biopharmaceutics, 60, pp. 407-412.
265. Mollica, G. (2007) Structure and dynamics of biological and pharmaceutical systems by solid-state NMR: Application to complex materials and methodological developments on model systems. Università di Pisa